ANDINA BOTTLING CO INC

AKO-A
About the company

Embotelladora Andina S.A., together with its subsidiaries, produces, bottles, commercializes, and distributes Coca-Cola trademark beverages in Chile, Brazil, Argentina, and Paraguay. It offers fruit juices, other fruit-flavored beverages, sport drinks, flavored waters, and mineral and purified water; iced tea and matte beverages; seed-based beverages; energy drinks; pre-mixed cocktails; and polyethylene terephthalate (PET) bottles and preforms, returnable PET bottles, cases, and plastic caps.

Country: ChilePrice: $25.29Market Cap: $4.0B

Investment snapshot

24%positive consensus
Scored 1d ago

Positive

3

BUY / PASS

Neutral / negative

6 / 7

NEUTRAL / FAIL

Median fair value

$3.63

-85.6% vs price

Models with upside

2 / 17

Positive margin of safety

Strongest signal

9 of 10 pass — Oshaughnessy objects

Key risk

11 of 12 flag AKO-A's debt & leverage — Graham, Buffett, Lynch +8 more

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILBUY · Rank #230 (Top 7.4%)NEUTRALNEUTRALPASSNEUTRALFAILFAILNEUTRALFAILPASSNEUTRALPASSFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/A
Margin of Safety-35.5%+20.5%-16.1%-15.8%N/A-9.8%-35.5%-37.7%-0.4%-39.6%+18.8%-67.9%N/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2025

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025 · Market data at 2026-11-01

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025 · Market data at 2026-11-01

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-04-01

Score computed: 2026-11-14

Where It Passes

  • Cash Flow90% pass✓ 11✗ 1▾

    9 of 10 pass — Oshaughnessy objects

    Free Cash Flow Proxy$298.6M
    ✓BuffettPositive and growing
    FCF Positive and Growing$203.7M
    ✓LynchPositive and growing
    Operating Cash Flow$512.4M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=13.48%, ROA=7.86%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)7.8x
    ✓Dreman< 8x
    P/E or FCF YieldP/E=13.4x, FCF Yield=5.1%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive11/11 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap5.1%
    ✓Ackman>= 4%
    Price / FCF per Share19.6x
    ✓Ackman<= 25
    Positive Operating Cash Flow frequency11/11 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$203.7M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+5.11%; #1560/4519 (top 34.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Growth75% pass✓ 11✗ 2▾

    6 of 8 pass — Lynch and Sleep object

    EPS Growth (3-yr avg, 10-yr window)84.6%
    ✓Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)1.16
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR11.5%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthN/A (no inventory)
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction$0.13 (2015) -> $0.32 (2025)
    ✓DremanPositive over recent years
    EPS CAGR9.2% CAGR over 10 years
    ✓Dreman> 5% annualized
    Positive Net Income Frequency11/11 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth9.7%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency3/4 years with positive EPS growth
    ✓AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR13.2% CAGR over 4 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trend
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR9.2%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR13.2% over 4 years
    ✓Neff7%-20% annualized

Where It Falls Short

  • Debt & Leverage8% pass✓ 1✗ 14▾

    11 of 12 flag AKO-A's debt & leverage — Graham, Buffett, Lynch +8 more

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest Coverage
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity
    ✗Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities1.41
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity
    ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
    Debt Levels
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=6.6x, D/EBITDA=N/A
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity
    ✗Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)
    ✗AsnessTop 30% of eligible cross-section
  • Efficiency13% pass✓ 2✗ 9▾

    7 of 8 flag AKO-A's efficiency — Graham, Buffett, Piotroski +4 more

    Current Ratio1.41
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)
    ✗Buffett> 10%
    ROIC - WACC
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)37.9%
    ✓Greenblatt> 25%
    Current Ratio Change YoY1.12 -> 1.41
    ✓PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.98x -> 0.98x
    ✗PiotroskiImproved YoY
    Current Assets / Current Liabilities1.41
    ✗Dreman> 1.5
    Return on Invested Capital
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)
    ✗SleepROIC > 12% in a majority of years
  • Valuation models18% pass✓ 2✗ 9▾

    Models split on AKO-A at $25.29 — fair values range $2.51–$5.30

    Graham fair value$3.11
    ✗Graham-35.5% margin vs $25.29
    Buffett fair value$5.30
    ✓Buffett+20.5% margin vs $25.29
    Lynch fair value$3.63
    ✗Lynch-16.1% margin vs $25.29
    Greenblatt fair value$3.64
    ✗Greenblatt-15.8% margin vs $25.29
    Dreman fair value$3.84
    ✗Dreman-9.8% margin vs $25.29
    Munger fair value$3.11
    ✗Munger-35.5% margin vs $25.29
    Pabrai fair value$3.06
    ✗Pabrai-37.7% margin vs $25.29
    Akre fair value$4.20
    ✗Akre-0.4% margin vs $25.29
    Marks fair value$3.02
    ✗Marks-39.6% margin vs $25.29
    Ackman fair value$5.19
    ✓Ackman+18.8% margin vs $25.29
    Templeton fair value$2.51
    ✗Templeton-67.9% margin vs $25.29
  • Verdicts36% pass✓ 4✗ 7▾

    Split decision: 7 FAIL · 6 NEUTRAL · 3 PASS

    Overall verdict
    ✗GrahamFAIL (2/9)✗BuffettFAIL (3/9)✗LynchFAIL (4/7)✓GreenblattRank #230•PiotroskiNEUTRAL (F-Score 7)•DremanNEUTRAL (7/11)✓MungerPASS (2/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (2/6)✗MarksFAIL (3/5)•AckmanNEUTRAL (7/9)✗TempletonFAIL (3/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✓NeffPASS (6/6)✗SchlossFAIL (3/7)•OshaughnessyNEUTRAL (Not ranked)
  • Valuation38% pass✓ 11✗ 17▾

    8 of 13 flag AKO-A's valuation — Graham, Lynch, Dreman +5 more

    Net income / market capitalization+7.48%; #1094/6340 (top 17.3%)
    ✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Price / 3-yr avg EPS16.5x
    ✗Graham<= 15x
    Price-to-Book Ratio3.1x
    ✗Graham<= 1.5x
    P/E x P/B51.10
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)1.16
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value13.6%
    ✓Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=13.6%, ROC=37.9%
    ✓GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS13.4x
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)7.8x
    ✓Dreman< 8x
    Price / Book Value per Share3.1x
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessP/E=13.4x, OE Yield=4.2%
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldP/E=13.4x, FCF Yield=5.1%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/E=13.4x, P/B=3.1x
    ✓MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value-9.8% (IV=$3.84 vs Price=$4.22)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per Share19.6x
    ✓Ackman<= 25
    Price vs. Trailing Low170% of trailing low ($2.48)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Positive book equity / market capitalization+0.3223; #3595/6449 (top 55.7%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS13.4x
    ✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E1.40
    ✓Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share11.94x
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change+1.8%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.9316; #1843/5247 (top 35.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+5.11%; #1560/4519 (top 34.5%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date+5.82%; #2104/6202 (top 33.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Profitability44% pass✓ 24✗ 11▾

    9 of 16 flag AKO-A's profitability — Graham, Buffett, Lynch +6 more

    Net income / market capitalization+7.48%; #1094/6340 (top 17.3%)
    ✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive EPS (10 years)9/12 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)84.6%
    ✓Graham>= 33% growth
    Net Income Positive (10+ years)11/12 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)19.1%
    ✓Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)
    ✗BuffettStable or rising over 10 years
    Free Cash Flow Proxy$298.6M
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)0.29
    ✓BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)1.16
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR11.5%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    ROE23.2%
    ✓Lynch> 15%
    EBIT / Enterprise Value13.6%
    ✓Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=13.6%, ROC=37.9%
    ✓GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets7.86%
    ✓PiotroskiROA > 0
    ROA Change YoY7.07% -> 7.86% (delta: +0.79%)
    ✓PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=13.48%, ROA=7.86%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY39.7% -> 39.1%
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue11.4%
    ✓Dreman>= 8%
    Net Income / Shareholders' Equity23.2%
    ✓Dreman> 12%
    Margin of SafetyP/E=13.4x, P/B=3.1x
    ✓PabraiP/B < 1.5 or P/E < 15
    Return on Equity22.1% (3-yr avg)
    ✓AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value-9.8% (IV=$3.84 vs Price=$4.22)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency11/11 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue
    ✗Ackman>= 15%
    Net Income / Shareholders Equity23.2%
    ✓Ackman>= 15%
    5-Year EPS CAGR13.2% CAGR over 4 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trend
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Gross profit / total assets+38.22%; #1021/3702 (top 27.6%)
    ✓AsnessTop 30% of eligible cross-section
    Net income / positive book equity+23.22%; #664/5226 (top 12.7%)
    ✓AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0130; #1019/5884 (top 17.3%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR13.2% over 4 years
    ✓Neff7%-20% annualized
    Positive Diluted-EPS Years8/8 years positive
    ✓Schloss>= 70% positive over 5-10 observed years (app rule)

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Candy & Soda
SIC Sector: Food Products
Size: Mid Cap($4.0B)
Revenue: $3.7B+14.5% YoY
Net Income: $298.6M+27.5% YoY

Financial Snapshot

Operating Margin--
Return on Equity23.2%
Debt / Equity--
Current Ratio1.41
EPS (Diluted)$0.32+27.5% 1y
Shares Retired0.0% / 0.0% 2y

Shareholder Return

Fiscal 2025

Retired 0.0% of shares last year, 0.0% over two.

Buybacks
—
Dividends
$217.7M

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY22
−19.3% = −19.3% + −0.0%
FY23
32.2% = 32.2% + 0.0%
FY24
20.9% = 20.9% + 0.0%
FY25
27.5% = 27.5% + −0.0%
Earnings Fewer shares More shares

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

MetricFY 2025
Sources
  • 20-F · 2026-04-01
FY 2024
Sources
  • 20-F · 2025-03-26
FY 2023
Sources
  • 20-F · 2024-03-27
FY 2022
Sources
  • 20-F · 2023-04-26
FY 2021
Sources
  • 20-F · 2022-04-27
Market Cap$4.0Bcurrent$14.1Best.$9.7Best.$9.2Best.$6.6Best.
Revenue$3.7B↑15%$3.2B↑10%$3.0B↓5%$3.1B↑19%$2.6B
Operating Income----------
Net Income$298.6M↑27%$234.2M↑21%$193.8M↑32%$146.6M↓19%$181.7M
EPS (Diluted)$0.32↑27%$0.25↑21%$0.20↑32%$0.15↓19%$0.19
Gross Margin39.1%↓1%39.7%↑2%38.8%38.7%↑2%38.0%
Operating Margin—————
ROE23.2%↓3%23.8%↑23%19.3%↑32%14.7%↑2%14.4%
Total Debt----------
Shareholders' Equity$1.3B↑31%$982.9M↓2%$1.0B$999.1M↓21%$1.3B
Current Ratio1.41↑26%1.12↓21%1.42↑16%1.22↓35%1.87
Debt / Equity—————
Operating Cash Flow$512.4M↑42%$359.6M↓13%$414.7M↓11%$464.3M↑30%$358.3M
Free Cash Flow$203.7M↑208%$66.1M↓66%$196.8M↓20%$246.2M↑26%$195.2M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Candy & Soda

AKO-A vs Peers — Financial Grading

Revenue$3.7BMedian
Net Income$298.6MMedian
ROE23.2%Top 25%
D/E—
Op. Margin—
Curr. Ratio1.41Median
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
Monster Beverage CorpMNST$90.9B$46.46$8.3B$1.9B23.1%—29.2%3.702/96/92/71/3F-Score 66/11
COCA-COLA EUROPACIFIC PARTNERS plcCCEP$52.0B$118.57$24.6B$2.3B24.8%1.3013.4%0.801/91/95/70/3F-Score 73/11
MEXICAN ECONOMIC DEVELOPMENT INCFMX$44.9B$131.91$37.9B$2.0B13.5%0.49—1.691/91/90/71/3F-Score 45/11
COCA COLA FEMSA SAB DE CVKOF$25.3B$120.63$13.6B$1.2B16.5%0.50—1.121/90/91/71/3F-Score 74/11
Coca-Cola Consolidated, Inc.COKE$14.3B$214.34$7.2B$570.6M-77.1%-3.7713.2%1.262/95/91/71/3F-Score 52/11
Celsius Holdings, Inc.CELH$8.1B$32.42$2.5B$108.0M9.1%0.575.6%1.682/92/94/71/3F-Score 47/11
NATIONAL BEVERAGE CORPFIZZ$3.5B$37.23$1.2B$183.6M28.9%—19.5%4.392/95/92/71/3F-Score 65/11
Zevia PBCZVIA$78.0M$1.08$161.3M$9.9M-19.4%0.00-7.3%2.082/91/92/70/3F-Score 52/11